Soteria Battery Innovation Group has exclusively licensed and optioned a technology developed by Oak Ridge National Laboratory designed to eliminate thermal runaway in lithium ion batteries due to mechanical damage.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
Prometheus Fuels has licensed an ethanol-to-jet-fuel conversion process developed by researchers at Oak Ridge National Laboratory. The ORNL technology will enable cost-competitive production of jet fuel and co-production of butadiene for use in renewable polymer synthesis.
ORNL scientists have modified a single microbe to simultaneously digest five of the most abundant components of lignocellulosic biomass, a big step forward in the development of a cost-effective biochemical conversion process to turn plants into renewable fuels and chemicals.
Oak Ridge National Laboratory researchers have designed and additively manufactured a first-of-its-kind aluminum device that enhances the capture of carbon dioxide emitted from fossil fuel plants and other industrial processes.
Oak Ridge National Laboratory scientists evaluating northern peatland responses to environmental change recorded extraordinary fine-root growth with increasing temperatures, indicating that this previously hidden belowground mechanism may play an important role in how carbon-rich peatlands respond to warming.
Joe Hagerman, ORNL research lead for buildings integration and controls, understands the impact building technology innovations can have during times of crisis. Over a decade ago, he found himself in the middle of one of the most devastating natural disasters of the century, Hurricane Katrina.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.